Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
May 09, 2003
INTERNATIONAL IMMUNIZATION NEWS
“Indian Biotechnology Firm Launches Low-Cost Typhoid Vaccine”
Agence France Presse (www.afp.com/english/home) (05/09/03)
India's Bharat Biotech has launched its new typhoid vaccine Typbar. The vaccine will cost patients 175 rupees, about 25 rupees less than it costs to purchase vaccine imported from other countries, according to Bharat chairman Krishna Ella, and the company plans to reduce the price by 100 rupees in the near future. Producing the typhoid vaccine cost 170 million over two years, and Ella noted that the U.S. National Institutes of Health provided assistance. Each year, said Ella, approximately 16 million people worldwide contract typhoid, including about 6 million in India, and about 600,000 people die from the disease.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.